Skip to main content

Advertisement

Log in

Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature

  • ORIGINAL ARTICLE
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

The treatment of choice for duodenal neuroendocrine tumors (NETs) ranges from endoscopic resection and local excision to pancreaticoduodenectomy. The aim of this study was to investigate the optimal treatment for this tumor.

Methods

We retrospectively analyzed the clinicopathological data of 14 patients with NETs in the second portion of the duodenum who underwent surgery in our hospital from 2000 to 2015. The duodenal NETs were classified as either ampullary or non-ampullary. Additionally, a systematic review and pooled analysis was conducted.

Results

Among eight patients with ampullary NETs and six patients with non-ampullary NETs, seven and three patients underwent pancreaticoduodenectomy and one and three patients underwent local resection, respectively. The maximum tumor diameter were 11–30 mm in ampullary and 10–100 mm in non-ampullary NETs, respectively. In patients with ampullary NETs, lymph node metastases were suspected in only three cases preoperatively, but five patients actually had regional nodal metastases. Among patients with non-ampullary NETs, lymph node metastases were suspected in none preoperatively, but three of the four patients who underwent lymph node dissection had regional nodal metastases. According to a pooled analysis of 1245 patients in 88 studies, even small tumors confined to the submucosal layer and G1 tumors—ampullary and non-ampullary—have been associated with lymph node metastases. In patients with non-ampullary NETs and lymph node metastasis, 10-year recurrence-free survival rate was 51% for patients who underwent pancreaticoduodenectomy (n = 19) and 53% for patients who underwent partial duodenal resection (n = 9), respectively (p = 0.960).

Conclusion

Lymph node metastases were common in association with both ampullary and non-ampullary NETs, and it was difficult to radiologically diagnose metastases. Additionally, there were no clinicopathological factors that could reliably predict the absence of lymph node metastases preoperatively. Therefore, to maximize the ability to achieve a curative resection, pancreaticoduodenectomy is considered appropriate in well-conditioned patients with NETs in the second portion of the duodenum. However, to further clarify the impact of lymph node dissection on survival after duodenal NET resection, a multi-institutional study with a large number of patients, thorough examination of lymph node metastasis, and a long observation period is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063–3072

    Article  PubMed  Google Scholar 

  2. Oberndorfer S (1907) Karzinoide Tumoren des Dünndarms. Frankf Z Pathol 1:425–432

    Google Scholar 

  3. WHO (2010) Classification of Tumours of the Digestive System. 4th ed: WHO PRESS

  4. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M (2010) Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 45(2):234–243

    Article  PubMed  Google Scholar 

  5. Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, Sasano H, Tomassetti P, Salazar R, Ruszniewski P, Barcelona Consensus Conference p (2012) ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 95(2):74–87

    Article  CAS  PubMed  Google Scholar 

  6. Soga J (2003) Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res 22(3):349–363

    CAS  PubMed  Google Scholar 

  7. Witzigmann H, Loracher C, Geissler F, Wagner T, Tannapfel A, Uhlmann D, Caca K, Hauss J, Hehl JA (2002) Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy. Langenbeck’s Arch Surg 386(7):525–533

    Article  Google Scholar 

  8. Clements WM, Martin SP, Stemmerman G, Lowy AM (2003) Ampullary carcinoid tumors: rationale for an aggressive surgical approach. J Gastrointest Surg 7(6):773–776

    Article  PubMed  Google Scholar 

  9. Hartel M, Wente MN, Sido B, Friess H, Buchler MW (2005) Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol 20(5):676–681

    Article  PubMed  Google Scholar 

  10. Makhlouf HR, Burke AP, Sobin LH (1999) Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer 85(6):1241–1249

    Article  CAS  PubMed  Google Scholar 

  11. Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, Fong Y, Allen PJ, D’Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Tang LH (2014) Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. J Gastrointest Surg 18(3):457–462

    Article  PubMed  Google Scholar 

  12. National_Comprehensive_Cancer_Network (2016) Neuroendocrine Tumors Version 2.2016

  13. Miyazaki M, Ohtsuka M, Miyakawa S, Nagino M, Yamamoto M, Kokudo N, Sano K, Endo I, Unno M, Chijiiwa K, Horiguchi A, Kinoshita H, Oka M, Kubota K, Sugiyama M, Uemoto S, Shimada M, Suzuki Y, Inui K, Tazuma S, Furuse J, Yanagisawa A, Nakanuma Y, Kijima H, Takada T (2015) Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci 22(3):181–196

  14. TNM (2009) Classifacation of Malignat Tumours. 7 th ed: Wiley-Blackwell

  15. Scherubl H, Jensen RT, Cadiot G, Stolzel U, Kloppel G (2010) Neuroendocrine tumors of the small bowels are on the rise: early aspects and management. World J Gastrointest Endosc 2(10):325–334

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M, International Study Group on Pancreatic Fistula D (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13

    Article  PubMed  Google Scholar 

  17. Lee JH, Lee KG, Ha TK, Jun YJ, Paik SS, Park HK, Lee KS (2011) Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma. Am Surg 77(3):322–329

    PubMed  Google Scholar 

  18. Rose DM, Hochwald SN, Klimstra DS, Brennan MF (1996) Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 183(2):89–96

    CAS  PubMed  Google Scholar 

  19. Winter JM, Cameron JL, Olino K, Herman JM, de Jong MC, Hruban RH, Wolfgang CL, Eckhauser F, Edil BH, Choti MA, Schulick RD, Pawlik TM (2010) Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 14(2):379–387

    Article  PubMed  Google Scholar 

  20. Kato Y, Takahashi S, Kinoshita T, Shibasaki H, Gotohda N, Konishi M (2014) Surgical procedure depending on the depth of tumor invasion in duodenal cancer. Jpn J Clin Oncol 44(3):224–231

    Article  PubMed  Google Scholar 

  21. Kachare SD, Liner KR, Vohra NA, Zervos EE, Fitzgerald TL (2014) A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival. Am Surg 80(8):821–826

    PubMed  Google Scholar 

  22. Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW (2009) Neuroendocrine tumors of the ampulla of Vater: biological behavior and surgical management. Arch Surg 144(6):527–531

    Article  PubMed  Google Scholar 

  23. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB (2005) Carcinoid tumors of the duodenum. Surgery 138(6):971–977 discussion 977-978

    Article  PubMed  Google Scholar 

  24. Tsai SD, Kawamoto S, Wolfgang CL, Hruban RH, Fishman EK (2015) Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation. Abdom Imaging 40(5):1121–1130

    Article  PubMed  PubMed Central  Google Scholar 

  25. Baumann T, Rottenburger C, Nicolas G, Wild D (2016) Gastroenteropancreatic neuroendocrine tumours (GEP-NET)—imaging and staging. Best Pract Res Clin Endocrinol Metab 30(1):45–57

    Article  PubMed  Google Scholar 

  26. Cameron JL, Riall TS, Coleman J, Belcher KA (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244(1):10–15

    Article  PubMed  PubMed Central  Google Scholar 

  27. Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, Hruban RH, Cameron JL (2000) Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231(6):890–898

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Odabasi M, Yildiz KM, Cengiz E, Hasan AH, Gunay E, Ozkan E, Aktekin A, Kaya B, Muftuoglu TM (2013) Treatment of ampullary neuroendocrine tumor by endoscopic snare papillectomy. Am J Case Rep 14:439–443

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kim GH, Kim JI, Jeon SW, Moon JS, Chung IK, Jee SR, Kim HU, Seo GS, Baik GH, Lee YC, Korean College of H, Upper Gastrointestinal R (2014) Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol 29(2):318–324

    Article  PubMed  Google Scholar 

  30. Zhang RC, Xu XW, Wu D, Zhou YC, Ajoodhea H, Chen K, Mou YP (2013) Laparoscopic transduodenal local resection of periampullary neuroendocrine tumor: a case report. World J Gastroenterol 19(39):6693–6698

    Article  PubMed  PubMed Central  Google Scholar 

  31. Tsujimoto H, Ichikura T, Nagao S, Sato T, Ono S, Aiko S, Hiraki S, Yaguchi Y, Sakamoto N, Tanimizu T, Yamamoto J, Hase K (2010) Minimally invasive surgery for resection of duodenal carcinoid tumors: endoscopic full-thickness resection under laparoscopic observation. Surg Endosc 24(2):471–475

    Article  PubMed  Google Scholar 

  32. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Miyazaki I (1997) Surgical strategy for carcinoma of the papilla of vater on the basis of lymphatic spread and mode of recurrence. Surgery 121(6):611–617

    Article  CAS  PubMed  Google Scholar 

  33. Moriya T, Kimura W, Hirai I, Mizutani M, Ma J, Kamiga M, Fuse A (2006) Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater. J Hepato-Biliary-Pancreat Surg 13(6):549–555

    Article  Google Scholar 

  34. Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA (2014) Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol 21(11):3515–3521

    Article  PubMed  PubMed Central  Google Scholar 

  35. Albores-Saavedra J, Hart A, Chable-Montero F, Henson DE (2010) Carcinoids and high-grade neuroendocrine carcinomas of the ampulla of vater: a comparative analysis of 139 cases from the surveillance, epidemiology, and end results program-a population based study. Arch Pathol Lab Med 134(11):1692–1696

    PubMed  Google Scholar 

  36. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269 W264

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi Nara.

Ethics declarations

None of the authors have conflicts of interest associated with the publication of this article. Because our institutional review board approves the conduction of retrospective cohort studies on an occasional basis, the present study was exempt from obtaining additional statements of informed consent from each patient. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iwasaki, T., Nara, S., Kishi, Y. et al. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Langenbecks Arch Surg 402, 925–933 (2017). https://doi.org/10.1007/s00423-016-1537-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-016-1537-6

Keywords

Navigation